ALL COMPANIES

This formulation of Ambroxol acts as a GCase enhancer and is designed to improve glucocerebrosidase activity to treat Parkinson's disease...

A formulation of Ambroxol as a GCase enhancer, aimed at supporting GCase activity and reducing toxic buildup in cells to...

Ambroxol as a GCase enhancer is used to enhance glucocerebrosidase activity, targeting the progression of Parkinson's disease by addressing cellular...

This is a small molecule functioning as a GCase enhancer, with the aim of boosting the activity of glucocerebrosidase to...

This formulation of Ambroxol acts as a GCase enhancer and is being explored for its effects on both cognition/dementia and...

Infudopa (levodopa/carbidopa, LD/CD) is a small molecule that provides a dopamine precursor  to treat motor impairment in Parkinson's disease by...

Lu-AF28996 is a small molecule dopamine receptor agonist that targets motor impairment and "OFF" episodes (periods when medication isn't working)....

SER-214 is a small molecule dopamine receptor agonist. It aims to alleviate motor impairment by activating dopamine receptors and enhancing...

Armesocarb (MLR-1019) is a dopamine reuptake inhibitor designed to reduce dyskinesia by increasing dopamine availability in the brain, thereby modulating...